Universities innovate, Big Pharma develops: Public and philanthropic funding crucial to treat cancer

As FRANCE 24 marks World Most cancers Day, François Picard welcomes Lars Henning Milman Engelholm, Affiliate Professor and Group Chief on the Finsen Laboratory, Rigshospitalet / Biotech Analysis & Innovation Centre (BRIC), College of Copenhagen. From his lab in Copenhagen, Professor Engelholm describes a seismic shift underway in pancreatic most cancers analysis, the results of a decade-long dedication to the regular evolution of translational science.



Source link